Literature DB >> 25958204

Buforin IIb induces endoplasmic reticulum stress-mediated apoptosis in HeLa cells.

Ju Hye Jang1, Yu Jin Kim1, Hyun Kim1, Sun Chang Kim2, Ju Hyun Cho3.   

Abstract

Buforin IIb, a novel cell-penetrating anticancer peptide derived from histone H2A, has been reported to induce mitochondria-dependent apoptosis in tumor cells. However, increasing evidence suggests that endoplasmic reticulum and mitochondria cooperate to signal cell death. In this study, we investigated the mechanism of buforin IIb-induced apoptosis in human cervical carcinoma HeLa cells by focusing on ER stress-mediated mitochondrial membrane permeabilization. Two-dimensional PAGE coupled with MALDI-TOF and western blot analysis showed that buforin IIb treatment of HeLa cells resulted in upregulation of ER stress proteins. PBA (ER stress inhibitor) and BAPTA/AM (Ca(2+) chelator) pretreatment rescued viability of buforin IIb-treated cells through abolishing phosphorylation of SAPK/JNK and p38 MAPK. SP600125 (SAPK/JNK inhibitor) and SB203580 (p38 MAPK inhibitor) attenuated down-regulation of Bcl-xL/Bcl-2, mitochondrial translocation of Bax, and cytochrome c release from mitochondria. Taken together, our data suggest that the ER stress pathway has an important role in the buforin IIb-induced apoptosis in HeLa cells.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticancer peptide; Apotosis; Buforin IIb; ER stress; Mitochondrial membrane permeabilization

Mesh:

Substances:

Year:  2015        PMID: 25958204     DOI: 10.1016/j.peptides.2015.04.024

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  9 in total

Review 1.  Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.

Authors:  Jacek Zielonka; Joy Joseph; Adam Sikora; Micael Hardy; Olivier Ouari; Jeannette Vasquez-Vivar; Gang Cheng; Marcos Lopez; Balaraman Kalyanaraman
Journal:  Chem Rev       Date:  2017-06-27       Impact factor: 60.622

Review 2.  Strategies for Liposome Drug Delivery Systems to Improve Tumor Treatment Efficacy.

Authors:  Jia Wang; Junbo Gong; Zhenping Wei
Journal:  AAPS PharmSciTech       Date:  2021-12-14       Impact factor: 3.246

3.  Antidepressants Fluoxetine Mediates Endoplasmic Reticulum Stress and Autophagy of Non-Small Cell Lung Cancer Cells Through the ATF4-AKT-mTOR Signaling Pathway.

Authors:  Shali Shao; Xibing Zhuang; Lin Zhang; Tiankui Qiao
Journal:  Front Pharmacol       Date:  2022-05-10       Impact factor: 5.988

4.  The Anticancer Activity Conferred by the Mud Crab Antimicrobial Peptide Scyreprocin through Apoptosis and Membrane Disruption.

Authors:  Ying Yang; Hui-Yun Chen; Hua Hao; Ke-Jian Wang
Journal:  Int J Mol Sci       Date:  2022-05-14       Impact factor: 6.208

5.  Liposomes equipped with cell penetrating peptide BR2 enhances chemotherapeutic effects of cantharidin against hepatocellular carcinoma.

Authors:  Xue Zhang; Congcong Lin; Aiping Lu; Ge Lin; Huoji Chen; Qiang Liu; Zhijun Yang; Hongqi Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

6.  ER stress and autophagy are involved in the apoptosis induced by cisplatin in human lung cancer cells.

Authors:  Shaomin Shi; Ping Tan; Bingdi Yan; Rong Gao; Jianjun Zhao; Jing Wang; Jia Guo; Ning Li; Zhongsen Ma
Journal:  Oncol Rep       Date:  2016-03-16       Impact factor: 3.906

7.  2-Deoxy-d-glucose Promotes Buforin IIb-Induced Cytotoxicity in Prostate Cancer DU145 Cells and Xenograft Tumors.

Authors:  Yangke Wanyan; Xixi Xu; Kehang Liu; Huidan Zhang; Junai Zhen; Rong Zhang; Jumei Wen; Ping Liu; Yuqing Chen
Journal:  Molecules       Date:  2020-12-07       Impact factor: 4.411

8.  VLX1570 regulates the proliferation and apoptosis of human lung cancer cells through modulating ER stress and the AKT pathway.

Authors:  Juan Wang; Tongde Du; Ya Lu; Yan Lv; Yuxin Du; Jianzhong Wu; Rong Ma; Chenxin Xu; Jifeng Feng
Journal:  J Cell Mol Med       Date:  2021-12-01       Impact factor: 5.310

9.  In Vitro and In Vivo Inhibitory Effect of Gujin Xiaoliu Tang in Non-Small Cell Lung Cancer.

Authors:  Chao Hou; Dai-Han Zhou; Yong-Jian Wu; Xiao-Jun Dai; Qing-Ying Wang; Yin-Qiu Wu; En-Xin Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-09       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.